About this trial
This clinical trial evaluates whether a three-dimensional (3D)-printed external breast prosthesis improves patient-reported outcomes (PRO) among breast cancer patients that underwent surgical removal of the breast (mastectomy) without surgical reconstruction. Breast cancer remains a significant health concern and often requires a mastectomy. While breast reconstruction is a common option following a mastectomy, some patients decide not to undergo it or are not candidates. An external breast prosthesis is worn on the outside of the body to replace the breast that was removed during the mastectomy. Traditional external breast prostheses may lack comfort and fit. A 3D-printed external breast prosthesis is customized to the patient using 3D imaging along with computer-aided design (CAD) to interpret the 3D imaging to develop and print a patient-specific external breast prosthesis. This may create a better fitting prosthesis which may improve PRO.
Eligibility criteria
Qualifiers
Adult individuals aged 18 years or older
History of unilateral or bilateral mastectomy for any indication
No implant or autologous reconstruction
Allowed: Goldilocks closure, flat closure, simple skin closure
Disqualifiers
Individuals with contraindications for participation, such as severe medical conditions that may interfere with study procedures
Lack of willingness or capacity to provide informed consent for study participation
Inability to communicate effectively in the study language (e.g., English)
Patients with open wounds, active infection, or dermatologic conditions at the chest/breast site that would interfere with scanning, fiducial marker placement, or prosthesis use
Trial design
Treatments tested in this trial
- Computer-Aided Diagnosis
- Prosthetics Intervention
- Prosthetics Intervention
- Prosthetics Intervention
- Questionnaire Administration